Precision Medicine Quarterly

Roche launches comprehensive genomic profiling kit to expand access to personalized cancer research

2021-10-25T16:54:02-05:00October 25th, 2021|

Roche today announced that it has launched the AVENIO Tumor Tissue CGP Kit. The Kit complements the current CGP portfolio offered by Roche and Foundation Medicine and allows laboratories to expand their oncology research in-house. Ultimately, a future version of the kit may lead to additional resources for clinicians to use in the diagnosis and [...]

Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL

2021-10-15T09:54:53-05:00October 15th, 2021|

Illumina, Inc. (NASDAQ:ILMN) announced that Bob Ragusa has been appointed as Chief Executive Officer of GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, effective immediately. GRAIL currently operates as a separate and independent unit of Illumina. "With over three decades of experience in genomics, Bob possesses the strategic vision and [...]

PathAI Announces Strategic Partnership with Roche to Enable Development and Distribution of Digital Pathology Diagnostics

2021-10-15T09:25:57-05:00October 15th, 2021|

PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Roche, a global pioneer in pharmaceuticals and diagnostics, announced a strategic partnership to develop and distribute PathAI’s AI-powered technology through Roche’s uPath enterprise software, enabling broad access to digital pathology diagnostics to support clinical research and companion diagnostic (CDx) programs globally. AI-powered [...]

Terasaki Institute for Biomedical Innovation Signs Agreement with Qatar Foundation

2021-10-14T15:38:37-05:00October 14th, 2021|

The Terasaki Institute for Biomedical Innovation (TIBI) has recently signed an agreement with Qatar Foundation. Qatar Foundation is comprised of over 50 entities and is a non-profit organization that supports work in education, research, and community development. Under the umbrella of Qatar Foundation's Research, Development, and Innovation division (QF RDI), the Qatar Genome Programme [...]

Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencing

2021-10-14T10:20:57-05:00October 14th, 2021|

Pillar Biosciences, an innovative, next-generation sequencing (NGS) solutions, in-vitro diagnostics company, today announced that it has entered into an agreement with Labcorp (NYSE: LH), a leading global life sciences company, to provide genomic testing for people with cancer. Under the agreement, Pillar Biosciences will provide the oncoReveal™ Essential Myeloproliferative Neoplasm (MPN) panel. Using NGS, [...]

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

2021-10-14T10:04:13-05:00October 14th, 2021|

Agilent Technologies Inc. (NYSE: A)  announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered. This is the first IHC [...]

Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases

2021-10-14T09:59:24-05:00October 14th, 2021|

Amgen (NASDAQ: AMGN) and Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company pioneering precision medicines for brain diseases, announced a strategic collaboration to advance neuroscience discovery, development and commercialization. The companies will collaborate on programs by applying Neumora's proprietary precision neuroscience platform to insights generated by Amgen's deCODE genetics and human data research capabilities. [...]

Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration

2021-10-14T09:57:05-05:00October 14th, 2021|

Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, and Ono Pharmaceutical Co., Ltd. ("Ono"), an R&D-oriented pharmaceutical company committed to novel drug discovery and development, announced a strategic collaboration to leverage Caris' best-in-class molecular profiling, including its novel, liquid biopsy circulating nucleic acids sequencing (cNAS) assay, across several [...]

Bionano Genomics to Acquire BioDiscovery

2021-10-14T09:52:48-05:00October 14th, 2021|

Bionano Genomics, Inc. (BNGO) announced that it has entered into a definitive agreement to acquire BioDiscovery, Inc., a leading software company with best-in-class solutions for analysis, interpretation and reporting of genomics data. The transaction is expected to accelerate and broaden Bionano’s market leadership in digital cytogenetics and comprehensive genome analysis. As a result of the [...]

Go to Top